Today: 15 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Verizon CEO Just Drew a Line on Free Phones. Customers Should Read the Fine Print

Verizon CEO Just Drew a Line on Free Phones. Customers Should Read the Fine Print

Verizon Communications CEO Dan Schulman is tightening the screws on giveaways, pulling back from the practice of handing out free phones and service lines to retain customers. Schulman is wagering that improvements in service and more precise marketing can keep users loyal without leaning on those costly promotions. “We are no longer giving away lines for free,” Schulman said, as reported by TheStreet.
6 May 2026
Oil Plunges As Trump Halts Hormuz Mission And Iran Deal Hopes Surge

Oil Plunges As Trump Halts Hormuz Mission And Iran Deal Hopes Surge

President Donald Trump abruptly halted a brief U.S. naval push to escort commercial vessels through the Strait of Hormuz. According to Reuters, which cited a Pakistani mediation source, Washington and Tehran are nearing agreement on a one-page memorandum aimed at ending the Gulf war. Oil prices tumbled on the developments, with traders reading the moves as the strongest indication so far that diplomatic talks are outpacing preparations for conflict.
6 May 2026
Cellectar Biosciences Stock: $140 Million Deal Puts Iopofosine FDA Filing in Focus

Cellectar Biosciences Stock: $140 Million Deal Puts Iopofosine FDA Filing in Focus

Cellectar Biosciences on Tuesday secured up to $140 million in new funding and rolled out fresh 12-month results for its iopofosine I 131 program, giving the cancer drug maker a shot of cash for a planned confirmatory trial and a potential U.S. submission in Waldenström macroglobulinemia. The company pegged the overall response rate at 83.6% from its Phase 2b CLOVER WaM trial, targeting this rare blood cancer.
1 100 101 102 103 104 882

Stock Market Today

  • BSE Sensex Sheds 561 Points to 77,054.94 as Oil Jumps, Iran Worries Weigh
    July 14, 2026, 9:28 PM EDT. BSE Sensex dropped 561.46 points, or 0.72%, closing at 77,054.94 on July 14, 2026. Crude oil moved higher and US-Iran military tensions picked up, hitting equities across sectors. Investors also took in weak earnings guidance from a major tech name. The index saw its sharpest one-day loss in weeks, with traders wary of the latest geopolitical worries and the impact of higher energy prices.
Go toTop